Search

Your search keyword '"Clarke, Blaise A."' showing total 24 results

Search Constraints

Start Over You searched for: Author "Clarke, Blaise A." Remove constraint Author: "Clarke, Blaise A." Publisher wiley-blackwell Remove constraint Publisher: wiley-blackwell
24 results on '"Clarke, Blaise A."'

Search Results

1. Transforming diagnostics: The implementation of digital pathology in clinical laboratories.

2. Validation of BRCA testing on cytologic samples of high‐grade serous carcinoma.

3. Maximizing cancer prevention through genetic navigation for Lynch syndrome detection in women with newly diagnosed endometrial and nonserous/nonmucinous epithelial ovarian cancer.

4. Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: An individual patient data meta‐analysis.

5. Tumor and germline next generation sequencing in high grade serous cancer: experience from a large population‐based testing program.

6. Performance characteristics of screening strategies to identify Lynch syndrome in women with ovarian cancer.

7. Expanding the morphological spectrum of ovarian microcystic stromal tumour.

8. Efficacy evaluation of a novel vectorized anti‐tau antibody, targeting a C‐terminal phospho‐tau epitope, using systemic dosing of a blood brain barrier penetrant AAV capsid in mouse models of tauopathies.

9. Genomic profiling identifies <italic>GPC5</italic> amplification in association with sarcomatous transformation in a subset of uterine carcinosarcomas.

10. Clinical, morphological and immunohistochemical evidence that small-cell carcinoma of the ovary of hypercalcaemic type ( SCCOHT) may be a primitive germ-cell neoplasm.

11. Loss of SMARCA4 (BRG1) protein expression as determined by immunohistochemistry in small-cell carcinoma of the ovary, hypercalcaemic type distinguishes these tumours from their mimics.

12. Ovarian hilar proliferations resembling Sertoli cell tumours: microscopic neoplasms or non-neoplastic remnants?

13. In‐depth molecular profiling of the biphasic components of uterine carcinosarcomas.

14. Microscopic extraovarian sex cord proliferations: an undescribed phenomenon.

15. Performance characteristics of screening strategies for Lynch syndrome in unselected women with newly diagnosed endometrial cancer who have undergone universal germline mutation testing.

16. Novel PRKD gene rearrangements and variant fusions in cribriform adenocarcinoma of salivary gland origin.

17. Review of findings in prophylactic gynaecological specimens in Lynch syndrome with literature review and recommendations for grossing.

18. No small surprise - small cell carcinoma of the ovary, hypercalcaemic type, is a malignant rhabdoid tumour.

19. Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancy.

20. Molecular determinants of outcome with mammalian target of rapamycin inhibition in endometrial cancer.

21. Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomas.

22. Hedgehog pathway signaling in cervical carcinoma and outcome after chemoradiation.

23. Comparison of clinical schemas and morphologic features in predicting Lynch syndrome in mutation-positive patients with endometrial cancer encountered in the context of familial gastrointestinal cancer registries.

24. Mutations in IDH1 and IDH2 are not present in sporadic ovarian sex cord-stromal tumours.

Catalog

Books, media, physical & digital resources